Methods for treating polymicrobial infections
AssigneeCap Diagnostics, LLC
InventorsDavid A. Baunoch, Miguel F. R. Penaranda, Michael L. Opel, Maher Badir, Natalie Luke
Life of this patent
Estimating the term…
Abstract
Methods for detecting and treating polymicrobial infections, wherein a mixed population of microbes (e.g., bacteria) are present in a patient sample and the microbes are not first isolated from the sample. For example, the present invention describes specific polymicrobial infections and methods of treating said infections, wherein a particular antibiotic or a group of antibiotics are selected based on the composition of the polymicrobial infections.
Claims4
A method for treating a patient having or suspected of having a polymicrobial infection comprising a combination of Escherichia coli (E. coli) and coagulase-negative Staphylococcus (CoNS), the method comprising:
- a. detecting the presence of both E. coli and CoNS in a source of the infection obtained from the patient;
- and
- b. administering to the patient a therapeutically effective amount of an antibiotic selected from the group consisting of:
- (i) a combination of amoxicillin and clavulanate;
- (ii) ceftriaxone;
- (iii) tetracycline or doxycycline;
- and (iv) a combination of trimethoprim and sulfamethoxazole;
- wherein the E. coli and CoNS together have a decreased odds of resistance to one or more of the antibiotics, and wherein the antibiotics are effective for killing or inhibiting growth of the E. coli and CoNS to treat the polymicrobial infection.
A method for treating a patient having or suspected of having a polymicrobial infection comprising a combination of Escherichia coli (E. coli) and coagulase-negative Staphylococcus (CoNS), the method comprising:
- a. detecting the presence of both E. coli and CoNS in a source of the infection obtained from the patient;
- and
- b. administering to the patient a therapeutically effective amount of an antibiotic selected from the group consisting of:
- (i) a combination of amoxicillin and clavulanate;
- and (ii) ceftriaxone;
- wherein the E. coli and CoNS together have a decreased odds of resistance to one or more of the antibiotics, and wherein the antibiotics are effective for killing or inhibiting growth of the E. coli and CoNS to treat the polymicrobial infection.
Dependencies are inferred from the claim text.